manufacturers of glp 1 drugs GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care GLP-1 Drug Savings: A Complete
Description
Exendin-4, a glucagonlike peptide-1 receptor agonist, attenuates breast cancer growth by inhibiting NF-B activation
No head-to-head trials comparing agents in these two classes are currently available to guide decision-making
[DOI] [PMC free article] [PubMed] [Google Scholar] 99
Improvements in access will take time, and require generation of compelling data (e.g., pharmacoeconomics, impact on comorbidities) and savvy commercial strategy
